The quest for an optimal definition of prostate-specific antigen failure following radical prostatectomy: the risk of not seeing the forest for the trees

Eur Urol. 2014 Aug;66(2):211-3. doi: 10.1016/j.eururo.2013.09.016. Epub 2013 Sep 19.

Authors

Guillaume Ploussard¹, James W Catto²

Affiliations

¹ Department of Urology, Saint-Louis Hospital, Assistance Publique Hopitaux de Paris, Paris, France. Electronic address: [email protected].
² Academic Urology Unit and Academic Unit of Molecular Oncology, The Medical School, University of Sheffield, Sheffield, UK.

PMID: 24075576
DOI: 10.1016/j.eururo.2013.09.016

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Male
Neoplasm Recurrence, Local / blood*
Neoplasm Recurrence, Local / pathology*
Prostate-Specific Antigen / blood*
Prostatic Neoplasms / blood*
Prostatic Neoplasms / pathology*
Salvage Therapy*

Substances

Prostate-Specific Antigen